Cargando…

Potentially inappropriate medication use among hypertensive older African-American adults

BACKGROUND: Inappropriate use of medications, particularly among minority older adults with co-morbidity, remains a major public health concern. The American Geriatrics Society (AGS) reports that Potentially Inappropriate Medication (PIM) continues to be prescribed for older adults, despite evidence...

Descripción completa

Detalles Bibliográficos
Autores principales: Bazargan, Mohsen, Smith, James L, King, Ebony O
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6173851/
https://www.ncbi.nlm.nih.gov/pubmed/30290768
http://dx.doi.org/10.1186/s12877-018-0926-9
_version_ 1783361196335824896
author Bazargan, Mohsen
Smith, James L
King, Ebony O
author_facet Bazargan, Mohsen
Smith, James L
King, Ebony O
author_sort Bazargan, Mohsen
collection PubMed
description BACKGROUND: Inappropriate use of medications, particularly among minority older adults with co-morbidity, remains a major public health concern. The American Geriatrics Society (AGS) reports that Potentially Inappropriate Medication (PIM) continues to be prescribed for older adults, despite evidence of poor outcomes. The main objective of this study was to examine the prevalence of PIM use among underserved non-institutionalized hypertensive older African-American adults. Furthermore, this study examines potential correlations between PIM use and the number and type of chronic conditions. METHODS: This cross-sectional study is comprised of a convenience sample of 193 hypertensive non-institutionalized African-American adults, aged 65 years and older recruited from several senior housing units located in underserved areas of South Los Angeles. The updated 2015 AGS Beers Criteria was used to identify participants using PIMs. RESULTS: Almost one out of two participants had inappropriate medication use. While the average number of PIMs taken was 0.87 drugs, the range was from one to seven medications. Almost 23% of PIMs were due to drugs with potential drug-drug interactions. The most common PIM was the use of proton pump inhibitors (PPI) and Central Nervous System (CNS) active agents. Nearly 56% of PIMs potentially increased the risk of falls and fall-associated bone fractures. The use of PIMs was significantly higher among participants who reported a higher number of chronic conditions. Nearly 70% of participants with PIM use reported suffering from chronic pain. CONCLUSIONS: The major reason for high levels of polypharmacy, PIMs, and drug interactions is that patients suffer from multiple chronic conditions. But it may not be possible or necessary to treat all chronic conditions. Therefore, the goals of care should be explicitly reviewed with the patient in order to determine which of the many chronic conditions has the greatest impact on the life goals and/or functional priorities of the patient. Those drugs that have a limited impact on the patient’s functional priorities and that may cause harmful drug-drug interactions can be reduced or eliminated, while the remaining medications can focus on the most important functional priorities of the patient.
format Online
Article
Text
id pubmed-6173851
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-61738512018-10-15 Potentially inappropriate medication use among hypertensive older African-American adults Bazargan, Mohsen Smith, James L King, Ebony O BMC Geriatr Research Article BACKGROUND: Inappropriate use of medications, particularly among minority older adults with co-morbidity, remains a major public health concern. The American Geriatrics Society (AGS) reports that Potentially Inappropriate Medication (PIM) continues to be prescribed for older adults, despite evidence of poor outcomes. The main objective of this study was to examine the prevalence of PIM use among underserved non-institutionalized hypertensive older African-American adults. Furthermore, this study examines potential correlations between PIM use and the number and type of chronic conditions. METHODS: This cross-sectional study is comprised of a convenience sample of 193 hypertensive non-institutionalized African-American adults, aged 65 years and older recruited from several senior housing units located in underserved areas of South Los Angeles. The updated 2015 AGS Beers Criteria was used to identify participants using PIMs. RESULTS: Almost one out of two participants had inappropriate medication use. While the average number of PIMs taken was 0.87 drugs, the range was from one to seven medications. Almost 23% of PIMs were due to drugs with potential drug-drug interactions. The most common PIM was the use of proton pump inhibitors (PPI) and Central Nervous System (CNS) active agents. Nearly 56% of PIMs potentially increased the risk of falls and fall-associated bone fractures. The use of PIMs was significantly higher among participants who reported a higher number of chronic conditions. Nearly 70% of participants with PIM use reported suffering from chronic pain. CONCLUSIONS: The major reason for high levels of polypharmacy, PIMs, and drug interactions is that patients suffer from multiple chronic conditions. But it may not be possible or necessary to treat all chronic conditions. Therefore, the goals of care should be explicitly reviewed with the patient in order to determine which of the many chronic conditions has the greatest impact on the life goals and/or functional priorities of the patient. Those drugs that have a limited impact on the patient’s functional priorities and that may cause harmful drug-drug interactions can be reduced or eliminated, while the remaining medications can focus on the most important functional priorities of the patient. BioMed Central 2018-10-05 /pmc/articles/PMC6173851/ /pubmed/30290768 http://dx.doi.org/10.1186/s12877-018-0926-9 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Bazargan, Mohsen
Smith, James L
King, Ebony O
Potentially inappropriate medication use among hypertensive older African-American adults
title Potentially inappropriate medication use among hypertensive older African-American adults
title_full Potentially inappropriate medication use among hypertensive older African-American adults
title_fullStr Potentially inappropriate medication use among hypertensive older African-American adults
title_full_unstemmed Potentially inappropriate medication use among hypertensive older African-American adults
title_short Potentially inappropriate medication use among hypertensive older African-American adults
title_sort potentially inappropriate medication use among hypertensive older african-american adults
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6173851/
https://www.ncbi.nlm.nih.gov/pubmed/30290768
http://dx.doi.org/10.1186/s12877-018-0926-9
work_keys_str_mv AT bazarganmohsen potentiallyinappropriatemedicationuseamonghypertensiveolderafricanamericanadults
AT smithjamesl potentiallyinappropriatemedicationuseamonghypertensiveolderafricanamericanadults
AT kingebonyo potentiallyinappropriatemedicationuseamonghypertensiveolderafricanamericanadults